These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15213710)

  • 21. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?
    Ibrahimpasic T; Ghossein R; Carlson DL; Nixon IJ; Palmer FL; Patel SG; Tuttle RM; Shaha A; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4193-7. PubMed ID: 25893415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of papillary thyroid cancer suspected by high anti-thyroglobulin antibody levels and detection of peripheral blood thyroglobulin mRNA.
    Coelho SM; Buescu A; Corbo R; Carvalho DP; Vaisman M
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1321-5. PubMed ID: 19169488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
    Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
    J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
    Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
    Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
    Baudin E; Do Cao C; Cailleux AF; Leboulleux S; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1107-11. PubMed ID: 12629092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study.
    Bellantone R; Lombardi CP; Bossola M; Ferrante A; Princi P; Boscherini M; Maussier L; Salvatori M; Rufini V; Reale F; Romano L; Tallini G; Zelano G; Pontecorvi A
    Cancer; 2001 Nov; 92(9):2273-9. PubMed ID: 11745281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
    Roelants V; Nayer PD; Bouckaert A; Beckers C
    Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.
    Werner RA; Lückerath K; Schmid JS; Higuchi T; Kreissl MC; Grelle I; Reiners C; Buck AK; Lapa C
    Sci Rep; 2016 Jun; 6():28081. PubMed ID: 27306607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
    Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
    Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy.
    Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
    Br J Cancer; 2001 Jul; 85(1):102-6. PubMed ID: 11437410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR.
    Bojunga J; Röddiger S; Stanisch M; Kusterer K; Kurek R; Renneberg H; Adams S; Lindhorst E; Usadel KH; Schumm-Draeger PM
    Br J Cancer; 2000 May; 82(10):1650-5. PubMed ID: 10817499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definition of the Response to Initial Therapy with Radioiodine in Patients with Differentiated Thyroid Carcinoma: Basal or Stimulated Thyroglobulin?
    Rosario PW; Mourão GF; Calsolari MR
    Horm Metab Res; 2019 Oct; 51(10):634-638. PubMed ID: 31578049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
    Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
    J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.